Medtronic and the Manchester University UK National Health Service (NHS) Foundation Trust (MFT) have signed an agreement to co-develop healthcare technologies, including robotic surgery and AI-related initiatives.
The entities said their signing of what is claimed to be a UK-first Research, Development and Innovation (RDI) agreement will streamline collaboration on 鈥榤utually beneficial鈥� research and innovation projects across cardiovascular, neuroscience, medical surgery, and diabetes.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The latest agreement builds on an existing partnership that has resulted in improved care and clinical outcomes for patients over the past decade through piloting medtech solutions in MFT-operated hospitals, according to a joint statement by Medtronic and the MFT. These include the remote monitoring pathway TriageHP Plus, which has reduced the number of hospitalisations due to heart failure.
In October 2024, the National Institute for Health and Care Excellence (NICE) the pathway for heart failure patients with cardiac implantable electronic devices.
Medtronic UK and Ireland senior director Dr Matthew Williams-Gray commented: 鈥淏y co-developing novel solutions in cardiovascular, neuroscience, medical surgery, and diabetes, we aim to accelerate the transformation of healthcare and improve patient outcomes.鈥�
A key role for MFT under the RDI will be in facilitating the use of anonymised clinical data for public and private benefit through its Clinical Data Science Unit.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe pair-up will also involve the use of Medtronic鈥檚 product portfolio to increase remote patient monitoring and community care-based provisions on the NHS. MFT鈥檚 hosted infrastructure, including the National Institute for Health and Care Research (NIHR) HealthTech Research Centre (HRC) in Emergency and Acute Care, will support this aspect of the initiative.
More broadly, the RDI agreement resonates with technological strategies outlined under the UK Labour Government鈥檚 10-year plan for the NHS, which outlines shifts from hospital to more community-centred care and the transition from an analogue to a more digital health service.
To support these ambitions, the government announced a 拢29bn ($39.1bn) funding boost to the NHS in June, reflecting a 3% annual rise on current levels over the next three years to reach 拢226bn by 2029.
Dr Katherine Boylan, deputy managing director of research and innovation at MFT, commented: 鈥淭his collaboration provides a huge opportunity to pioneer breakthroughs in healthcare and accelerate our joint projects to design and deliver innovative research that will really make a difference in the NHS.鈥�
MFT鈥檚 latest agreement with Medtronic follows the release of a life sciences prospectus from Manchester鈥檚 Inward Investment Agency in June, the city has to play in the UK鈥檚 拢120bn life science ecosystem now and in the future.
